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Abstract: 
Objective: To analyse aqueous polymerase chain reaction (PCR) results in patients diagnosed with undifferentiated uveitis 
and determine prevalence of  herpesviridae in non-uveitic patients undergoing routine cataract extraction. 
Design: Retrospective comparative case series and prospective cross-sectional study. 
Subjects: 72 patients with idiopathic uveitis and 57 surgical patients. 
Methods: Diagnostic aqueous paracentesis with PCR testing for 6 herpes viridae in uveitic patients. Anterior chamber par-
acentesis immediately pre-operative in the prospective arm, with PCR testing. 
Results: In the retrospective review we had a 47.2% positive PCR yield. Data analysis revealed a statistically significant 
correlation between a positive yield and being HIV+ (p=0.018); between an EBV+ yield and being HIV+ (p= 0.026) and a 
CMV+ result and being HIV+ (p=0.032). Posterior uveitis (p=0.014) and symptoms <30 days (p= 0.0014) had a statistically 
significant yield. In the prospective arm of  the study: all 57 patients were HIV- and all aqueous samples were negative for 
the 6 herpesviridae. 
Conclusion: We recommend PCR testing for Herpesviridae as a safe second line test for patients with undifferentiated 
uveitis. We were unable to establish prevalence and suggest that the idea of  a commensal herpes virus is unlikely if  the 
blood-ocular barrier is intact.
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Introduction
Uveitis is internationally classified according to the an-
atomical locus of  infection: anterior (the anterior seg-
ment of  the eye), intermediate (anterior vitreous and 
par plana region), posterior (retina, optic nerve, vascu-
lature and posterior vitreous) and pan uveitis (involving 
all three anatomical locations). Anterior uveitis is the 
most common. Etiology varies widely according to the 
anatomical classification, age, immune status, pre-exist-
ing auto-immune diseases and exposure to toxins. Caus-
es can be divided into immune-mediated, infectious (vi-
ral, bacterial, parasitic, mycobacteria), associated with 
systemic diseases, drug related, a white-dot syndrome 
or masquerade syndrome (neoplastic and non-neoplas-
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tic). Prevalence studies often underestimate the cases of  
uveitis as many cases are undiagnosed, misdiagnosed or 
may be mild and patients do not seek medical attention. 
Prevalence is also dependant on the patient population 
group under question (rural vs urban, HIV prevalence 
in the community etc.). Despite advances in laborato-
ry testing, uveitis still poses many diagnostic challeng-
es. Routine management involves a detailed history, 
complete ocular examination, a physical examination 
and targeted baseline blood investigations. Laboratory 
workup may include the following tests: syphilis serolo-
gy, serum Angiotensin Conversion Enzyme, HLA-B27, 
HIV, Erythrocyte sedimentation rate and a full blood 
count. A chest X-ray is done and in selected cases sac-
ro-iliac imaging. If  the serum and radiological tests do 
not yield a definitive diagnosis, Cunningham et al sug-
gest that these patients be classified as having idiopath-
ic uveitis.1 More recently Jabs et al suggested the term 
“undifferentiated” should be used in uveitis that lacks 
an established non-infectious or infectious diagnosis.2 
Polymerase chain reaction (PCR) testing of  the aqueous 
humor has proven to be both a rapid and an accurate 
adjunct in the diagnosis of  infectious uveitis.3,4 It can 
detect herpes simplex virus 1 and 2 (HSV) as well as 
varicella zoster virus (VZV), which accounts for up to 
10% of  all uveitis cases seen at tertiary level referral 
centers.5  Epstein-Barr virus (EBV), cytomegalovirus 
(CMV) and human herpes virus 6 (HHV6) can also be 
detected by using PCR.6,7  
It is vital to remember that the presence of  DNA or 
RNA from an infectious agent does not prove causal-
ity.4 CMV, for example, establishes latent infection in 
myeloid progenitor cells and detection of  CMV DNA 
may therefore cause false positive results. EBV is char-
acterized by latency in B and T lymphocytes andepithe-
lial cells with the added ability to induce lymphoprolif-
eration. Studies detecting EBV DNA in non-inflamed 
cadaveric ocular tissues and aqueous humor of  immu-
nocompetent donors indicate a broad anatomic distri-
bution. Ongkosuwito et al documented an increased 
presence of  Epstein–Barr virus DNA in ocular fluid 
samples from HIV-negative immunocompromised pa-
tients where another infectious agent had been iden-
tified as the cause of  the uveitis (VZV, HSV, CMV + 
Toxoplasma gondii).8 A similar finding in our tertiary 
level unit prompted a review of  the PCR yield in our 
uveitic patients .
Our study consisted of  both a prospective and a retro-
spective component. In our retrospective study of  a co-
hort of  “idiopathic/undifferentiated uveitis” we aimed 
to: 1) analyze the PCR findings of  herpesviridae, 2) de-
termine whether a correlation exists between HIV sta-
tus and PCR findings, 3) explore correlations between 
CD4+ count and PCR yield, 4) consider clinical fea-
tures (retinitis, vasculitis and optic nerve involvement) 
and PCR yield and 5) probe correlations between onset 
of  symptoms and PCR yield. This would better char-
acterize established (HSV 1+2, VZV and CMV) and 
emerging (EBV and HHV6) forms of  viral uveitis. The 
prospective arm was designed to determine the preva-
lence of  herpesviridae in otherwise healthy eyes of  pa-
tients undergoing routine cataract surgery and to review 
their serum HIV results. This was not an age/gender 
matched control group to compare to the retrospective 
group. We were eager to gain insight into the commen-
sal status of  these viruses in non-uveitic eyes, if  any, in 
our local population. The results would hopefully allow 
us to make recommendations in the management of  
our challenging uveitis cases and more accurately inter-
pret the PCR results in our patient population. 
Methods
We conducted a retrospective evaluation of  vitreous 
fluid samples for six herpetic viruses from a list of  all 
aqueous samples received by the Tygerberg hospital Vi-
rology Department, from 01 January 2011 to 31 Decem-
ber 2012. Patient folders were then reviewed to identify 
patients with a diagnosis of  an “undifferentiated” uvei-
tis which was defined as active intraocular inflammation 
with a negative serological and radiological work-up 
on initial targeted testing.2 Patient characteristics and 
clinical features of  the uveitis were also recorded. The 
anatomical classification adhered to the Standardiza-
tion of  Uveitis Nomenclature (SUN) Working Group 
guidelines. Aqueous samples from this group of  pa-
tients were obtained in the out-patient department or in 
theatre after informed consent was taken. Strict aseptic 
techniques were employed: patients received topical an-
esthesia, followed by cleaning with povidone-iodine 5% 
solution. Thereafter, a sterile lid speculum was used and 
the anterior chamber paracentesis made with a 28-gauge 
12.7mm needle. On average a volume of  0.1ml – 0.2ml 
aqueous humor was removed. Post-procedure another 
drop of  povidone-iodine 5% was instilled. 
Patients for the prospective arm of  the study were en-
rolled from  a  single health facility in Cape Town  dur-
ing consultations between September 2012 and January 
2013. This group comprised a sample of  57 patients 
consenting to elective cataract surgery at Tygerberg 
Hospital, HIV testing and aqueous humor sampling. 
Inclusion criteria were: a) no active intraocular inflam-
mation on biomicroscopic examination; b) no evidence 
of  previous intra-ocular inflammation on history or bi-
omicroscopic examination; c) > 18yrs old; d) normal 
fundus examination pre-operative or day 1 post-op 
if  the cataract precluded a good view of  the fundus 
pre-operative. Any evidence of  previous intraocular in-
flammation, vitreo-retinal pathology and objection to 
serum HIV testing or aqueous sampling excluded pa-
tients from the study. On the day of  surgery patients 
received a local anaesthetic block, were cleaned with a 
povidone-iodine 5% solution and draped as per rou-
tine strict sterile technique. Initial entry into the ante-
rior chamber was made with a 28-gauge needle on an 
insulin syringe to extract 0.1ml – 0.2ml of  aqueous flu-
id just anterior to limbal blood vessels. The same sam-
ple site was then extended and used as a port during 
the rest of  the cataract surgery. After comprehensive 
pre-test counselling serum samples for HIV were ob-
tained. Samples were processed by the National Health 
Laboratory Services (NHLS) Virology Department Ty-
gerberg hospital, Cape Town, South Africa. There was 
strict adherence to the cold chain during transportation 
of  the aqueous samples to the laboratory. Patients who 
tested positive on the confirmatory HIV test received 
extensive post-test counselling and a further serum 
sample was taken to determine their CD4+ count and 
viral load. They were then referred to their nearest na-
tionally accredited Community Health Center for highly 
active anti-retroviral therapy (HAART) if  their CD4+ 
count was less than 350cells/mm3. Patients with a pos-
itive yield on aqueous PCR were re-evaluated clinically 
and referred to the Medical Retina Clinic for further 
management. 
Samples were processed using the qualitative Seeplex-
®Meningitis-V1 ACE Detection kit (Seegene Inc., Ko-
rea) with the understanding that this method had not 
been validated on ocular fluids, but cerebrospinal fluid 
(CSF).   This multiplex PCR kit employs dual priming 
oligonucleotide (DPO™) technology to detect 6 vi-
ruses (HSV-1, HSV-2, VZV, EBV, CMV and HHV-6). 
The DPO™ primer has two different priming portions 
which results in very specific amplification of  target 
DNA and consistently yields high PCR specificity even 
under sub-optimal PCR conditions. Limits of  detection 
(LoD) for the Seeplex® assays are: a) HSV-1 PCR: 100 
genomes/ml CSF; b) HSV-2 / VZV / EBV / CMV and 
HHV-6 PCR: 50 genomes/ml CSF and some studies 
show even lower LoD.9
Blood serum samples were screened for HIV using the 
third-generation immunoassays Abbot AxSym® HIV 
Ag/Ab Combo (Abbott Laboratories, Abbott Park, IL, 
USA) with a sensitivity of  100% and a specificity of  
99.87%. Confirmatory testing was done on all positive 
screening samples using the VIDAS HIV DUO Ultra 
(bioMérieux, Marcy l’Etoile, France) fourth-generation 
immunoassay. This test has a sensitivity of  100% and a 
specificity of  at least 99.5%, but has the advantage of  
being able to detect the p24 antigen during very ear-
ly HIV infection when viral loads are still low. Where 
applicable a Pan-leukogate CD4+ flow-based assay test 
was employed to calculate absolute CD4+ counts. All 
serum and aqueous tests were performed at our local 
laboratory, using routine test assays so as not to in-
troduce a variable between the two groups. Full panel 
herpesviridae screening is always done on all aqueous 
samples, as the cost difference between full panel versus 
partial panel testing is minimal.   
Statistical analysis of  the clinical data was completed by 
the Centre for Statistical Consultation of  the Universi-
ty of  Stellenbosch using MS Excel and STATISTICA 
version 10 [StatSoft Inc. (2011) STATISTICA (data 
analysis software system), www.statsoft.com]. Most 
variables were binary in nature and are presented using 
frequency distributions indicating absolute and relative 
counts.  When two categorical variables were compared 
Pearson’s chi-square test was used or a Fisher’s exact 
test in the case of  small expected frequencies.  Con-
tinuous variables such as age, CD4 count and duration 
since symptom onset were found to be non-normally 
distributed and when comparing these to PCR yield a 
Mann-Whitney U test was used. A p-value of  p < 0.05 
was used to indicate statistical significance.
The University of  Stellenbosch Health Research Ethics 
Committee approved both the retrospective compar-
ative case series and prospective cross-sectional study. 
Internationally accepted ethical standards and guide-
lines were respected and patient confidentiality protect-
ed.  
Results
There were 72 patients in the retrospective arm of  the 
study.  No complications during specimen collection 
were noted in any of  the medical records. Median age 
at time of  presentation was 30.5 years. Eighty percent 
of  the patients were between the ages of  20 and 50 
years old. Females accounted for 48 (66.7%) of  the co-
hort. Of  the patients, 43 had unilateral disease (59.7%), 
24 had bilateral simultaneous uveitis (33.3%) and 5 had 
bilateral asynchronous (6.9%) involvement. Clinically 
there were 18 cases of  anterior uveitis (25%), 1 of  in-
termediate uveitis (1.4%), 18 of  posterior uveitis (25%) 
and 35 of  pan uveitis (48.6%). Thirty three participants 
tested negative for HIV (45.8%) and were deemed im-
mune-competent. Thirty nine patients were HIV posi-
tive (54.2%). Only 14 of  the 39 (35.9%) were receiving 
highly active antiretroviral therapy (HAART) and half  
of  these had received treatment for 2 months or less. 
Of  the remaining 25 HIV-positive patients, 22/25 were 
either recently diagnosed and not yet on HAART or 
had defaulted treatment and in 3/25 the HIV status was 
unknown.  The CD4+ count of  2 of  the patients in 
the HIV positive group was not documented. Where 
information allowed, we reviewed the change in CD4+ 
count since commencing HAART (CD4+ count at na-
dir) and the CD4+ count on presentation to our unit. 
One patient who had been on first line therapy for 24 
months, with apparent good compliance, had a drop 
in her CD4+ count from 42 to 19 cells/mm3.  Table 1 
summarizes further patient details of  the HIV positive 
group.
Table 1. Details of the HIV positive patients  n = 39/72 
Data Median Interquartile range          25
th 
– 75th percentile
Age (yrs) 39/39 29 25 – 39 
CD4+ Count  (absolute) 37/39 155 60 – 260 
Period on HAART  (in months) 14/14 2mnths 1mnth – 15mnths 
Change in CD4+ count (absolute) since 
starting HAART and presenting  8/14 + 52 42.5 – 94.5 
Data = number of patients in that particular group where this information was known 
From the total of  72 patients, 34 PCR samples had 
a positive yield (47.2%), detecting 36 herpesviridae: 
HSV1 = 1; HSV2 = 4; VZV = 11; EBV = 12; CMV 
= 5; HHV6 = 3. Two HIV positive patients, both with 
a pan uveitis, tested positive for both VZV and EBV. 
Table 2 gives patient and clinical characteristics of  the 
positive PCR results. Data analysis revealed a statistical-
ly significant association between a positive PCR yield 
and being HIV+ (P = 0.0018); between an EBV posi-
tive yield and being HIV+ (P = 0.026) and a CMV pos-
itive result and being HIV+ (P = 0.032). VZV indicated 
a trend towards association (P = 0.179). 
Patients with posterior uveitis had a significantly high-
er PCR yield (P = 0.014) and CMV was found to be 
an important cause of  posterior uveitis (P = 0.0032). 
In contrast to previous reports from elsewhere, retini-
tis (P = 0.168), vasculitis (P = 0.181) and optic nerve 
involvement (P = 0.769) showed no relationship to a 
positive PCR yield3 in our study. A combination of  all 
three clinical features was also not noteworthy. No as-
sociation was found between gender and the anatomical 
classification of  the uveitis. 
Table 2. Clinical Characteristics of Positive PCR yield 
HIV status HSV1 (1) HSV2 (4) VZV (11) EBV (12) CMV (5) HHV6 (3) 
HIV Negative 1 2 3 2 2 
HIV Positive 2 8 10 5 1 
Classification HSV1 (1) HSV2 (4) VZV (11) EBV (12) CMV (5) HHV6 (3) 
Anterior Uveitis 3 1 1 
Intermediate 1 
Posterior Uveitis 1 2 4 4 
Panuveitis 1 3 6 6 1 2 
A CD4+ count of  less than 100 showed a trend to-
wards association with a positive PCR yield, but this 
was not statistically significant (P = 0.0588).  Boxplot 
1 shows the variability of  CD4+ counts when coupled 
with yield. Patients who presented within 30 days since 
the onset of  symptoms were more likely to acquire a 
definitive infectious diagnosis (P = 0.0014). 
Boxplot 1 
Boxplot 2 shows the distribution of  duration of  symp-
toms and the PCR results. Two of  our PCR negative 
patients were identified as Immune recovery uveitis.
The prospective arm of  the study enrolled fifty-seven 
patients. No intra-operative complications were record-
ed and all samples were suitable for analysis. Median 
age was 69 years old (lower quartile = 65.8 years; upper 
quartile = 71.2 years). Fifteen males constituted 26.3% 
of  the group.  All 57 patients were HIV negative and all 
aqueous samples were negative for the 6 herpesviridae. 
We were thus not able to establish prevalence.                    
Boxplot 2 
Discussion
Polymerase chain reaction analysis of  viral DNA allows 
rapid diagnosis from very small ocular samples. In the 
tertiary referral center where the study was performed 
it has been used more frequently over the last four years 
to assist in the diagnosis of  infectious uveitis. Analy-
sis of  aqueous humor specimens has been proven to 
be a safe and useful adjunct to a detailed history and 
thorough clinical examination.10 Collection of  the sam-
ple was remarkably well tolerated and did not result in 
any complications in these two cohorts of  patients. The 
median age of  presentation for the uveitic group was 
30.5 years and these patients are more inclined to have 
a non-syneritic vitreous body thereby increasing the 
likelihood of  a ‘dry tap’ on needle aspiration. Anteri-
or chamber sampling thus improves the probability of  
acquiring fluid for testing in a younger cohort. In cases 
with bilateral ocular involvement specimens were al-
ways collected from the eye with the worse visual acuity.
Until recently there was little published data on PCR 
analysis of  ocular fluids to identify infective causes of  
uveitis from Sub-Saharan Africa. In a study analysing 
viral, parasitic and mycobacterial PCR of  ocular fluids 
Scheepers et al noted that PCR confirmed the clinical 
diagnosis in 35% and altered the initial clinical diagnosis 
in 23% of  the patients with a posterior uveitis. Thir-
ty-nine percent of  the undifferentiated posterior uveitis 
cases had a definitive diagnosis after PCR testing. Their 
cohort also had a high percentage of  HIV+ patients and 
they documented about 50% qualifying for HAART, 
but not yet on treatment.11  In the retrospective arm of  
our study 35% of  the patients were eligible for, yet not 
receiving antiretroviral therapy; despite a robust rollout 
of  the Anti-retroviral program in South Africa. 
The retrospective review allowed us to identify patients 
in our local population who would benefit the most 
from aqueous herpetic screening. Harper et al identified 
6 factors that increased the chances of  a positive yield 
on PCR testing.3 Our study correlated with 3: immu-
nocompromise, early presentation and posterior uvei-
tis. We were unable to prove a statistically significant 
correlation between clinical presentation (retinitis, optic 
nerve involvement and vasculitis) and a positive PCR 
yield. We noted that a positive yield was independent 
of  the patients CD4+ count, but showed a trend to be 
more significant in patients with lower CD4+ counts. 
Studies with larger cohorts may confirm this. 
Early presentation was defined as: symptoms for less 
than 30 days. We attempted to define a more tempo-
ral relationship to the disease process; this was slight-
ly different to Harper’s definition of: testing within 2 
weeks of  presentation. The vast geographic size of  the 
area served by our eye unit and the poverty within our 
patient base pose many challenges to gaining access 
to tertiary level ophthalmic care. As a result there may 
be some delay in presentation and difficulty in reliable 
follow-up. In selected cases we might decide to do an 
aqueous tap at the time of  initial targeted testing, store 
this sample and send for formal analysis should the 
screening be negative. Our definition of  “early pres-
entation” is thus independent of  socio-economic cir-
cumstances and availability of  sample testing and more 
dependent on disease course. The extended period of  
detecting DNA post infection has been described pre-
viously using quantitative PCR to evaluate viral loads of  
VZV DNA in-patients undergoing treatment for acute 
retinal necrosis. There was a significant decrease in vi-
ral load (>102 copies/ml) at 50 days after commencing 
treatment with antiviral drugs.12 Confirming that PCR is 
still of  value in patients previously thought to be ‘pre-
senting late’. 
The role of  EBV as a cause for uveitis is unclear. 
Twelve of  our samples tested positive for EBV and 
there was a statistically significant association between 
the detection of  EBV in aqueous humor and HIV in-
fection.  Various studies, utilising serum IgG ELISA 
assays, have shown that EBV is hyperendemic in both 
HIV-seronegative and HIV-seropositive patients. A 
study in Ghana noted that the seroprevalence of  EBV 
was statistically significantly higher (p < 0.001) in HIV-
AIDS patients compared to HIV-seronegative healthy 
blood donors.13 This poses the question whether we are 
merely detecting leakage from the systemic circulation 
through an abnormally permeable blood-ocular barrier 
or detecting active replication within the eye ? EBV was 
first described in 1990 as a cause of  uveitis in 3 patients, 
validated by EBV IgG antibodies in the aqueous14 and 
was once demonstrated histologically in an enucleated 
uveitic eye.15 In 2009 Kim et al did a review of  cases 
in the literature and highlighted EBV’s propensity to 
being a co-pathogen16,17,18 most commonly with VZV. 
This finding is supported by two cases in this study that 
tested positive for both EBV and VZV. Our study made 
use of  a qualitative PCR technique and therefore can-
not comment on the quantum of  EBV present inside 
the eye. Future studies measuring the EBV viral load 
by quantitative PCR as well as possibly calculating an 
EBV Goldmann-Witmer Coefficient to look for anti-
body production against the virus may help to implicate 
or exonerate EBV as a pathogen. 
To our knowledge the prospective arm of  the study is 
the largest cohort of  healthy eyes where only aqueous 
samples were used and full panel Herpes viridae testing 
was done on all specimens. We were unable to establish 
prevalence and thus propose that the idea of  a com-
mensal herpes virus in the aqueous is unlikely if  the 
blood-ocular barrier is intact and the individual is im-
mune-competent. Larger studies are needed to support 
this theory. For example, a prospective study evaluating 
a cohort of  HIV positive patients with normal eyes, 
undergoing routine surgery may reveal different results 
and address some of  the short comings of  our group.
Clinical acumen and a thorough history should never be 
replaced by broad-based testing. We recommend PCR 
testing for herpes viridae in patients as a second line 
test as up to 50% of  these investigations may yield a 
causative infectious agent. HIV+ patients, patients pre-
senting with symptoms early and patients with posterior 
uveitis appear to have the most to gain in our setting. 
Larger studies need to be conducted, but thus far no 
commensal herpes viruses have been identified in our 
non-uveitic population. The results of  these two studies 
allow us to test more appropriately and thus institute 
anti-viral treatment promptly in challenging uveitis cas-
es in our local patient population.
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